» Articles » PMID: 33193699

Integration of Online Omics-Data Resources for Cancer Research

Overview
Journal Front Genet
Date 2020 Nov 16
PMID 33193699
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The manifestations of cancerous phenotypes necessitate alterations at different levels of information-flow from genome to proteome. The molecular alterations at different information processing levels serve as the basis for the cancer phenotype to emerge. To understand the underlying mechanisms that drive the acquisition of cancer hallmarks it is required to interrogate cancer cells using multiple levels of information flow represented by different omics - such as genomics, epigenomics, transcriptomics, and proteomics. The advantage of multi-omics data integration comes with a trade-off in the form of an added layer of complexity originating from inherently diverse types of omics-datasets that may pose a challenge to integrate the omics-data in a biologically meaningful manner. The plethora of cancer-specific online omics-data resources, if able to be integrated efficiently and systematically, may facilitate the generation of new biological insights for cancer research. In this review, we provide a comprehensive overview of the online single- and multi-omics resources that are dedicated to cancer. We catalog various online omics-data resources such as The Cancer Genome Atlas (TCGA) along with various TCGA-associated data portals and tools for multi-omics analysis and visualization, the International Cancer Genome Consortium (ICGC), Catalogue of Somatic Mutations in Cancer (COSMIC), The Pathology Atlas, Gene Expression Omnibus (GEO), and PRoteomics IDEntifications (PRIDE). By comparing the strengths and limitations of the respective online resources, we aim to highlight the current biological and technological challenges and possible strategies to overcome these challenges. We outline the available schemes for the integration of the multi-omics dimensions for stratifying cancer patients and biomarker prediction based on the integrated molecular-signatures of cancer. Finally, we propose the multi-omics driven systems-biology approaches to realize the potential of precision onco-medicine as the future of cancer research. We believe this systematic review will encourage scientists and clinicians worldwide to utilize the online resources to explore and integrate the available omics datasets that may provide a window of opportunity to generate new biological insights and contribute to the advancement of the field of cancer research.

Citing Articles

Pinpointing the integration of artificial intelligence in liver cancer immune microenvironment.

Bukhari I, Li M, Li G, Xu J, Zheng P, Chu X Front Immunol. 2025; 15():1520398.

PMID: 39759506 PMC: 11695355. DOI: 10.3389/fimmu.2024.1520398.


Review: Cancer and neurodevelopmental disorders: multi-scale reasoning and computational guide.

Nussinov R, Yavuz B, Demirel H, Arici M, Jang H, Tuncbag N Front Cell Dev Biol. 2024; 12:1376639.

PMID: 39015651 PMC: 11249571. DOI: 10.3389/fcell.2024.1376639.


CluF: an unsupervised iterative cluster-fusion method for patient stratification using multiomics data.

Shakyawar S, Sajja B, Patel J, Guda C Bioinform Adv. 2024; 4(1):vbae015.

PMID: 38698887 PMC: 11063539. DOI: 10.1093/bioadv/vbae015.


Chronic arsenic exposure induces malignant transformation of human HaCaT cells through both deterministic and stochastic changes in transcriptome expression.

Banerjee M, Srivastava S, Rai S, States J Toxicol Appl Pharmacol. 2024; 484:116865.

PMID: 38373578 PMC: 10994602. DOI: 10.1016/j.taap.2024.116865.


Cuproptosis-related gene as a prognostic indicator in non-small cell lung cancer: Functional involvement and regulation ofexpression.

Deng R, Zhu L, Jiang J, Chen J, Li H Biomol Biomed. 2023; 24(3):647-658.

PMID: 38041690 PMC: 11088889. DOI: 10.17305/bb.2023.9931.


References
1.
Jiang Y, Ma D, Suo C, Shi J, Xue M, Hu X . Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies. Cancer Cell. 2019; 35(3):428-440.e5. DOI: 10.1016/j.ccell.2019.02.001. View

2.
Cerami E, Gao J, Dogrusoz U, Gross B, Sumer S, Aksoy B . The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5):401-4. PMC: 3956037. DOI: 10.1158/2159-8290.CD-12-0095. View

3.
Kandoth C, McLellan M, Vandin F, Ye K, Niu B, Lu C . Mutational landscape and significance across 12 major cancer types. Nature. 2013; 502(7471):333-339. PMC: 3927368. DOI: 10.1038/nature12634. View

4.
Furey T . ChIP-seq and beyond: new and improved methodologies to detect and characterize protein-DNA interactions. Nat Rev Genet. 2012; 13(12):840-52. PMC: 3591838. DOI: 10.1038/nrg3306. View

5.
Hasin Y, Seldin M, Lusis A . Multi-omics approaches to disease. Genome Biol. 2017; 18(1):83. PMC: 5418815. DOI: 10.1186/s13059-017-1215-1. View